Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling

Dutt, S; Leichter, D; Cobigo, Y; Wolf, A; Kornak, J; Clark, A; Russell, LL; Bouzigues, A; Cash, DM; Bocchetta, M; Olzinski, M; Appleby, B; Bayram, E; Borroni, B; Bozoki, A; Butler, CR; Clark, D; Convery, RS; Darby, RR; de Mendonça, A; Dickerson, B; Domoto‐Reilly, K; Ducharme, S; Ferry‐Bolder, E

Journal article

Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling

Abstract:: Objective: Age of symptom onset is highly variable in familial frontotemporal lobar degeneration (f‐FTLD). Accurate prediction of onset would inform clinical management and trial enrollment. Prior studies indicate that individualized maps of brain atrophy can predict conversion to dementia in f‐FTLD. We used a Bayesian linear mixed‐effect (BLME) prediction method for identifying accelerated brain volume loss to predict conversion to dementia. Methods: Participants included 234 asymptomatic or prodromal carriers of C9orf72, GRN, or MAPT mutations (including 21 dementia converters) with ≥3 longitudinal magnetic resonance imaging (MRI) T1‐weighted scans. The BLME models established individual voxel‐wise gray matter trajectories using the first 2 scans. Person‐specific clusters of accelerated volume loss were estimated in subsequent scans and tested as predictors of dementia conversion compared with other approaches in time‐varying Cox proportional hazard models covarying for age. Receiver‐operating characteristic (ROC) curves estimated utility of cluster volume in discriminating which participants converted to dementia within 24 months. Results: The BLME cluster volume predicted conversion to dementia in f‐FTLD mutation carriers overall and separately in C9orf72, GRN, and MAPT, with comparable hazard ratios observed for atrophy W‐maps and regional volumes. Within a 24‐month timeframe, BLME cluster volume discriminated dementia converters from non‐converters with larger areas under the curve (AUCs) than other approaches. Interpretation: Bayesian‐modeled individualized atrophy scores predict dementia progression among asymptomatic f‐FTLD mutation carriers and may have increased utility compared with other structural imaging methods when studying individuals over shorter timeframes that align with clinical trial design. ANN NEUROL 2026

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Dutt, S., Leichter, D., Cobigo, Y., Wolf, A., Kornak, J., Clark, A., Russell, L. L., Bouzigues, A., Cash, D. M., Bocchetta, M., Olzinski, M., Appleby, B., Bayram, E., Borroni, B., Bozoki, A., Butler, C. R., Clark, D., Convery, R. S., Darby, R. R., … Ferry‐Bolder, E. (2026). Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling. Annals of Neurology.

MLA Style

Dutt, S, et al. “Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling.” Annals of Neurology, 2026.

Chicago Style

Dutt, S, D Leichter, Y Cobigo, et al. 2026. “Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling.” Annals of Neurology.
Print